| __timestamp | Amneal Pharmaceuticals, Inc. | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 84615000 | 305409000 |
| Thursday, January 1, 2015 | 109679000 | 377080000 |
| Friday, January 1, 2016 | 118757000 | 432829000 |
| Sunday, January 1, 2017 | 109046000 | 496079000 |
| Monday, January 1, 2018 | 230435000 | 557616000 |
| Tuesday, January 1, 2019 | 289598000 | 658498000 |
| Wednesday, January 1, 2020 | 326727000 | 770456000 |
| Friday, January 1, 2021 | 365504000 | 840100000 |
| Saturday, January 1, 2022 | 399700000 | 944700000 |
| Sunday, January 1, 2023 | 429675000 | 1136600000 |
| Monday, January 1, 2024 | 1464300000 |
In pursuit of knowledge
In the competitive landscape of pharmaceuticals, understanding spending patterns is crucial. Over the past decade, Vertex Pharmaceuticals Incorporated and Amneal Pharmaceuticals, Inc. have shown distinct trajectories in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Vertex's SG&A expenses surged by approximately 272%, reflecting its aggressive growth strategy and market expansion. In contrast, Amneal's expenses increased by about 408%, indicating its efforts to scale operations and enhance market presence.
These trends underscore the dynamic nature of the pharmaceutical industry, where strategic spending is pivotal for sustained growth.
Selling, General, and Administrative Costs: Pfizer Inc. vs Vertex Pharmaceuticals Incorporated
Breaking Down SG&A Expenses: Sanofi vs Amneal Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Vertex Pharmaceuticals Incorporated vs Zoetis Inc.
Vertex Pharmaceuticals Incorporated and Teva Pharmaceutical Industries Limited: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Vertex Pharmaceuticals Incorporated or Exelixis, Inc.
Operational Costs Compared: SG&A Analysis of Vertex Pharmaceuticals Incorporated and Opthea Limited
Selling, General, and Administrative Costs: Vertex Pharmaceuticals Incorporated vs Viridian Therapeutics, Inc.
Breaking Down SG&A Expenses: BioMarin Pharmaceutical Inc. vs Amneal Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Ascendis Pharma A/S or Amneal Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Amneal Pharmaceuticals, Inc. vs CymaBay Therapeutics, Inc.
Selling, General, and Administrative Costs: Amneal Pharmaceuticals, Inc. vs Soleno Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Amneal Pharmaceuticals, Inc. and MiMedx Group, Inc.